Cargando…
Short peptide pharmacophores developed from protein phosphatase-1 disrupting peptides (PDPs)
PP1 is a major phosphoserine/threonine-specific phosphatase that is involved in diseases such as heart insufficiency and diabetes. PP1-disrupting peptides (PDPs) are selective modulators of PP1 activity that release its catalytic subunit, which then dephosphorylates nearby substrates. Recently, PDPs...
Autores principales: | Fontanillo, Miriam, Trebacz, Malgorzata, Reinkemeier, Christopher D., Huerta, Daniela Avilés, Uhrig, Ulrike, Sehr, Peter, Köhn, Maja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613447/ https://www.ncbi.nlm.nih.gov/pubmed/35525109 http://dx.doi.org/10.1016/j.bmc.2022.116785 |
Ejemplares similares
-
Development of a
Photoactivatable Protein Phosphatase-1-Disrupting
Peptide
por: Trebacz, Malgorzata, et al.
Publicado: (2019) -
COVID PDPs
por: Tattar, R., et al.
Publicado: (2020) -
Synthesis of Highly Selective Submicromolar Microcystin‐Based Inhibitors of Protein Phosphatase (PP)2A over PP1
por: Fontanillo, Miriam, et al.
Publicado: (2016) -
Interrogating PP1 Activity in the MAPK Pathway with Optimized PP1‐Disrupting Peptides
por: Wang, Yansong, et al.
Publicado: (2018) -
Miklós Bodanszky Award Lecture: Advances in the selective targeting of protein phosphatase‐1 and phosphatase‐2A with peptides
por: Köhn, Maja
Publicado: (2017)